CVS Health Corp (CVS) : Intrust Bank Na reduced its stake in CVS Health Corp by 18.13% during the most recent quarter end. The investment management company now holds a total of 19,270 shares of CVS Health Corp which is valued at $1,877,476 after selling 4,266 shares in CVS Health Corp , the firm said in a disclosure report filed with the SEC on Aug 3, 2016.CVS Health Corp makes up approximately 0.74% of Intrust Bank Na’s portfolio.
Other Hedge Funds, Including , Mission Wealth Management reduced its stake in CVS by selling 323 shares or 8.52% in the most recent quarter. The Hedge Fund company now holds 3,466 shares of CVS which is valued at $337,692. CVS Health Corp makes up approx 0.08% of Mission Wealth Management’s portfolio.Clean Yield Group boosted its stake in CVS in the latest quarter, The investment management firm added 9,426 additional shares and now holds a total of 13,312 shares of CVS Health Corp which is valued at $1,234,422. CVS Health Corp makes up approx 0.53% of Clean Yield Group’s portfolio. Grimes Company added CVS to its portfolio by purchasing 2,536 company shares during the most recent quarter which is valued at $235,163. CVS Health Corp makes up approx 0.03% of Grimes Company’s portfolio.Capital Investment Advisors reduced its stake in CVS by selling 964 shares or 8.22% in the most recent quarter. The Hedge Fund company now holds 10,769 shares of CVS which is valued at $1,039,747. CVS Health Corp makes up approx 0.09% of Capital Investment Advisors’s portfolio.Ruane Cunniff Goldfarb Inc reduced its stake in CVS by selling 1,125 shares or 7.04% in the most recent quarter. The Hedge Fund company now holds 14,856 shares of CVS which is valued at $1,439,101. CVS Health Corp makes up approx 0.01% of Ruane Cunniff Goldfarb Inc’s portfolio.
CVS Health Corp closed down -0.19 points or -0.20% at $97.18 with 36,03,400 shares getting traded on Monday. Post opening the session at $97.37, the shares hit an intraday low of $96.85 and an intraday high of $97.62 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, CVS Health Corp reported $1.32 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.30. The company had revenue of $43725.00 million for the quarter, compared to analysts expectations of $44281.46 million. The company’s revenue was up 17.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.19 EPS.
Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Mizuho on Aug 4, 2016 to “Buy”, Firm has raised the Price Target to $ 111 from a previous price target of $108 .Company shares were Reiterated by Deutsche Bank on Aug 3, 2016 to “Hold”, Firm has raised the Price Target to $ 108 from a previous price target of $99 .Shares were Reiterated by Mizuho on Jun 23, 2016 to “Buy” and Lowered the Price Target to $ 108 from a previous price target of $117 .
CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.